These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 19801516)
1. Autoimmunity during thymectomy-induced lymphopenia: role of thymus ablation and initial effector T cell activation timing in nonobese diabetic mice. Gagnerault MC; Lanvin O; Pasquier V; Garcia C; Damotte D; Lucas B; Lepault F J Immunol; 2009 Oct; 183(8):4913-20. PubMed ID: 19801516 [TBL] [Abstract][Full Text] [Related]
2. Effects of intrathymic injection of organ-specific autoantigens, parietal cells, at the neonatal stage on autoreactive effector and suppressor T cell precursors. Murakami K; Maruyama H; Nishio A; Kuribayashi K; Inaba M; Inaba K; Hosono M; Shinagawa K; Sakai M; Masuda T Eur J Immunol; 1993 Apr; 23(4):809-14. PubMed ID: 8458371 [TBL] [Abstract][Full Text] [Related]
3. Organ-specific autoimmunity induced by adult thymectomy and cyclophosphamide-induced lymphopenia. Barrett SP; Toh BH; Alderuccio F; van Driel IR; Gleeson PA Eur J Immunol; 1995 Jan; 25(1):238-44. PubMed ID: 7843236 [TBL] [Abstract][Full Text] [Related]
4. Breakdown of self-tolerance by intrathymic injection of a T-cell line inducing autoimmune gastritis in mice. Nishio A; Katakai T; Hosono M; Inaba M; Sakai M; Okuma M; Kasakura S; Masuda T Immunology; 1995 Jun; 85(2):270-5. PubMed ID: 7642216 [TBL] [Abstract][Full Text] [Related]
5. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666 [TBL] [Abstract][Full Text] [Related]
6. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy. Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973 [TBL] [Abstract][Full Text] [Related]
7. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice. Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946 [TBL] [Abstract][Full Text] [Related]
8. Virus and autoimmunity: induction of autoimmune disease in mice by mouse T lymphotropic virus (MTLV) destroying CD4+ T cells. Morse SS; Sakaguchi N; Sakaguchi S J Immunol; 1999 May; 162(9):5309-16. PubMed ID: 10228006 [TBL] [Abstract][Full Text] [Related]
9. NOD fetal thymus organ culture: an in vitro model for the development of T cells involved in IDDM. Wilson SS; DeLuca D J Autoimmun; 1997 Oct; 10(5):461-72. PubMed ID: 9376074 [TBL] [Abstract][Full Text] [Related]
10. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway. Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677 [TBL] [Abstract][Full Text] [Related]
11. A novel mechanism of regulatory T cell-mediated down-regulation of autoimmunity. Qin HY; Mukherjee R; Lee-Chan E; Ewen C; Bleackley RC; Singh B Int Immunol; 2006 Jul; 18(7):1001-15. PubMed ID: 16675487 [TBL] [Abstract][Full Text] [Related]
12. Defective central tolerance in Aire-deficient mice is not sufficient to induce symptomatic autoimmunity during lymphopenia-induced T cell proliferation. Kekäläinen E; Lehto MK; Smeds E; Miettinen A; Meri S; Jarva H; Arstila TP Scand J Immunol; 2011 Jul; 74(1):71-9. PubMed ID: 21352256 [TBL] [Abstract][Full Text] [Related]
13. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment. You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382 [TBL] [Abstract][Full Text] [Related]
14. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis. Zipris D; Lazarus AH; Crow AR; Hadzija M; Delovitch TL J Immunol; 1991 Jun; 146(11):3763-71. PubMed ID: 1827815 [TBL] [Abstract][Full Text] [Related]
15. The mechanism of reduction of cell-mediated cytotoxicity in neonatally thymectomized mice. Kawauchi H; Taniguchi K; Kubo C; Shimamoto Y; Nomoto K Immunology; 1983 Oct; 50(2):199-205. PubMed ID: 6225727 [TBL] [Abstract][Full Text] [Related]
16. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse. Gallichan WS; Balasa B; Davies JD; Sarvetnick N J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077 [TBL] [Abstract][Full Text] [Related]
17. CD4+CD25+ naturally occurring regulatory T cells and not lymphopenia play a role in the pathogenesis of iodide-induced autoimmune thyroiditis in NOD-H2h4 mice. Nagayama Y; Horie I; Saitoh O; Nakahara M; Abiru N J Autoimmun; 2007; 29(2-3):195-202. PubMed ID: 17826032 [TBL] [Abstract][Full Text] [Related]
18. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. Suri-Payer E; Amar AZ; Thornton AM; Shevach EM J Immunol; 1998 Feb; 160(3):1212-8. PubMed ID: 9570536 [TBL] [Abstract][Full Text] [Related]